Pneumonia is a leading cause of serious illness throughout the world, and in the US, it is estimated that about one million adults get pneumococcal pneumonia each year. About 400,000 hospitalizations from pneumococcal pneumonia occur each year.
Researchers are studying an investigational vaccine intended to provide protection against pneumococcal disease in healthy adults ages 65 and older. This study will test the safety and effectiveness and safety of an investigational vaccination compared to an FDA-approved vaccine.
- Must be age 65+
- Must NOT have previously received a licensed or investigational pneumococcal vaccine
- Must NOT have previously had pneumococcal disease
- Will receive compensation for study-related time
- Do not need insurance to join this study
For more information, complete the form on this page. After you submit your information, a Meridian enrollment specialist will call you to talk about the study. There is no obligation to join — you can decide if the study is right for you.
You can talk to a Meridian enrollment specialist about this study by calling (402) 934-7563 (Omaha and Cincinnati) or (912) 623-2240 (Savannah).
Submit your information
Founded in 1999 in Omaha, NE, Meridian studies the safety and effectiveness of new medicines, devices, and treatments. Its mission is to enrich lives by providing quality, compassionate care to patients and unparalleled clinical research services. Clinical studies help scientists develop life-changing medicines, but it starts with you — participation makes it all possible. For more than 20 years, thousands of patients have trusted Meridian because of our focus on creating a positive patient experience.